In the study, body weight gain, carcass characteristics, and carcass quality traits were not affected by the length of supra-Se supplementation; however dry matter intake decreased linearly, possibly due to the decreased palatablity of the treatment diet.
While the non-supplemented treatment in the trial provided adequate Se to meet the RDA for humans, the Se concentration in lamb skeletal muscle for the 56-day Se-supplemented treatment would provide approximately 281% of the RDA for Se. No signs of Se toxicity were observed in the lambs.
While the non-supplemented treatment in the trial provided adequate Se to meet the RDA for humans, the Se concentration in lamb skeletal muscle for the 56-day Se-supplemented treatment would provide approximately 281% of the RDA for Se. No signs of Se toxicity were observed in the lambs.
Future efforts are needed to ascertain the targetted Se concentration in lamb muscle, the likely level of demand for a high-Se lamb product, and the marketing techniques required to deliver the product to the consumer. Similar studies have been undertaken with beef and pork.